This trial will test a new treatment for people with leukemia who have not responded to other treatments.
1 Primary · 5 Secondary · Reporting Duration: Study start date to study end date, or death, whichever comes first, up to 4 years
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: Venetoclax · No Placebo Group · Phase 2
Age 18 - 59 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: